Total submissions: 22
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041602 | SCV000065298 | benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | p.Ile529Ile in Exon 12 of SCN5A: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue, is not located with in the splice consensus sequence and has been identified in 0.9% (58/6814) of Eu ropean American chromosomes from a broad population by the NHLBI Exome Sequencin g Project (http://evs.gs.washington.edu/EVS; dbSNP rs45624133). |
Invitae | RCV000586395 | SCV000291781 | benign | not provided | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000041602 | SCV000306536 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000245011 | SCV000317779 | benign | Cardiovascular phenotype | 2014-12-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000586395 | SCV000700014 | benign | not provided | 2016-02-22 | criteria provided, single submitter | clinical testing | Variant summary: Variant affects a non-conserved nucleotide and results in a synonymous mutation. 5/5 in silico prediction tools via Alamut predict the variant not to have an effect on normal splicing and while mutation taster predicts the variant to be disease causing. The variant was found predominantly in the Finnish European subcohort of the ExAC project at an allele frequency of 1.5% indicating the variant to be a neutral polymorphism in individuals of Finnish origin. Moreover, a publication (Garca-Molina_ClinGen_2013) and a clinical diagnostic laboratory via ClinVar classifies variant as polymorphism/Benign. Considering all evidence, the variant was classified as Benign. |
Athena Diagnostics | RCV000586395 | SCV000843707 | benign | not provided | 2017-11-30 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001841591 | SCV000902705 | benign | Cardiac arrhythmia | 2018-03-08 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000586395 | SCV001157031 | benign | not provided | 2023-08-08 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001150021 | SCV001311028 | likely benign | Brugada syndrome 1 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Illumina Laboratory Services, |
RCV001150022 | SCV001311029 | likely benign | Dilated cardiomyopathy 1E | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Illumina Laboratory Services, |
RCV001150023 | SCV001311030 | likely benign | Ventricular fibrillation, paroxysmal familial, type 1 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Illumina Laboratory Services, |
RCV001150024 | SCV001311031 | likely benign | Progressive familial heart block, type 1A | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Illumina Laboratory Services, |
RCV001150025 | SCV001311032 | likely benign | Sick sinus syndrome 1 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Illumina Laboratory Services, |
RCV001150026 | SCV001311033 | likely benign | Long QT syndrome 3 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Ce |
RCV000586395 | SCV001371045 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | SCN5A: BP4, BP7, BS2 |
Gene |
RCV000586395 | SCV001839569 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003486623 | SCV004239651 | benign | Cardiomyopathy | 2022-11-16 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV001841591 | SCV004822704 | benign | Cardiac arrhythmia | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000586395 | SCV001744381 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000041602 | SCV001918066 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000041602 | SCV001951968 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000041602 | SCV001975531 | benign | not specified | no assertion criteria provided | clinical testing |